Schizophrenia (Disease or Phenotype)

Description: A disease or phenotype in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Schizophrenia's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target
5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone) Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
asparagine Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
2S-Aminobutyric acid Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-piperazin-1-yl)-ethoxy]-ethanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
5-Hydroxytryptophol Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
Taurine Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
cis-Gondoic acid Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
3b,17b-Dihydroxyetiocholane Metabolite (Entity type)	Correlated with condition Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
rel-Asenapine Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)

5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

asparagine
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

2S-Aminobutyric acid
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-piperazin-1-yl)-ethoxy]-ethanol
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

5-Hydroxytryptophol
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

Taurine
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

cis-Gondoic acid
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

3b,17b-Dihydroxyetiocholane
Metabolite (Entity type)
Correlated with condition
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

rel-Asenapine
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.